• oral il-23-blocking peptide racks up phase iii wins in inflammatory disease Nature Tue, 01 Apr 2025 10:55:00 GMT
• imbria pharmaceuticals to present results from phase 2 improve-dice trial of ninerafaxstat in patients with cardiometabolic hfpef ... GlobeNewswire Mon, 17 Mar 2025 07:00:00 GMT
• ryvu loses 30% of staff in focus on ph. 3 blood cancer trials Fierce Biotech Tue, 25 Feb 2025 08:00:00 GMT
• plaque psoriasis pipeline insights, fda approvals, clinical trials, emerging drugs and companies | delveinsight The Globe and Mail Wed, 29 Jan 2025 00:35:10 GMT
• eli lilly scientific chief skovronsky says scorpion deal ‘checked all the boxes’ statnews.com Mon, 13 Jan 2025 08:00:00 GMT
• eli lilly acquires cancer program from scorpion therapeutics in $2.5b deal statnews.com Mon, 13 Jan 2025 08:00:00 GMT
• combos, new moas, and oral formulations of injectables: lilly’s immunology strategy insights.citeline.com Wed, 20 Nov 2024 08:00:00 GMT
• shareholder investigation: halper sadeh llc investigates dice, q GuruFocus.com Sat, 02 Nov 2024 08:07:50 GMT
• Eli Lilly rolls the dice, axing psoriasis prospect and pivoting to follow-up 1 year after $2.4B buyout Fierce Biotech Wed, 30 Oct 2024 07:00:00 GMT
• mounjaro's sales likely to rise 2.5x driving eli lilly's q3 performance Forbes Mon, 28 Oct 2024 07:00:00 GMT
• for bristol myers squibb's newly approved schizophrenia drug, what a long, strange trip it's been FiercePharma Mon, 07 Oct 2024 07:00:00 GMT
• finance watch: bain capital raises $3bn for fourth life sciences fund Scrip Thu, 12 Sep 2024 07:00:00 GMT
• candid debuts with $370m, targets leadership in t cell engager space BioSpace Tue, 10 Sep 2024 07:00:00 GMT
• candid therapeutics launches with $370m to tackle autoimmunity with t-cell engagers BioPharma-Reporter.com Tue, 10 Sep 2024 07:00:00 GMT
• RayzeBio, Dice alums raise $370 million for new autoimmune startup statnews.com Mon, 09 Sep 2024 07:00:00 GMT
• Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies Business Wire Mon, 09 Sep 2024 07:00:00 GMT
• With $370M debut, Candid Therapeutics is upfront about goal to lead a coming T-cell engager wave Fierce Biotech Mon, 09 Sep 2024 07:00:00 GMT
• long-term ixekizumab similarly efficacious in challenging body areas in psoriasis Healio Sun, 01 Sep 2024 07:00:00 GMT
• lilly to test zepbound in psoriasis to follow up on weight-loss success BNN Bloomberg Tue, 20 Aug 2024 07:00:00 GMT
• avalo therapeutics announces appointment of dr. mittie doyle as chief medical officer GlobeNewswire Tue, 16 Jul 2024 07:00:00 GMT
• lilly to pay $3.2 billion for springer lab spin-out morphic Chemical & Engineering News Tue, 09 Jul 2024 07:00:00 GMT
• eli lilly's $3.2b morphic deal is 'crucial,' has 'strategic merit' despite investor attention on obesity: analyst Markets Insider Tue, 09 Jul 2024 07:00:00 GMT
• Eli Lilly Shows Appetite for Oral Immunology Drugs, Swallowing Morphic in $3.2B Deal MedCity News Mon, 08 Jul 2024 07:00:00 GMT
• Eli Lilly to acquire Morphic Holding Inc. in a $3.2 billion deal TechTarget Mon, 08 Jul 2024 07:00:00 GMT
• lilly inks $3.2b morphic buyout to snag oral rival to takeda's ibd blockbuster Fierce Biotech Mon, 08 Jul 2024 07:00:00 GMT
• lilly discloses its first biotech acquisition of the year, buying morphic for $3.2b Endpoints News Mon, 08 Jul 2024 07:00:00 GMT
• lilly beefs up bowel disease drug portfolio with $3.2 bln morphic deal Reuters Mon, 08 Jul 2024 07:00:00 GMT
• kirkland & ellis advises eli lilly in $3.2 billion morphic buy Bloomberg Law News Mon, 08 Jul 2024 07:00:00 GMT
• dice therapeutics | biotechnology | the pharmaletter The Pharma Letter Mon, 01 Jul 2024 00:22:45 GMT
• are medical stocks lagging catalyst pharmaceuticals (cprx) this year? Yahoo Movies UK Tue, 11 Jun 2024 18:06:13 GMT
• dice announces pricing of upsized public offering of common stock Quantisnow Wed, 05 Jun 2024 18:37:47 GMT
• johnson & johnson agrees to acquire yellow jersey therapeutics TechTarget Wed, 29 May 2024 07:00:00 GMT
• is dice therapeutics (dice) outperforming other medical stocks this year? Yahoo Lifestyle UK Mon, 27 May 2024 23:23:27 GMT
• dice therapeutics (dice) up 37% on buyout offer from eli lilly Yahoo Movies Canada Thu, 23 May 2024 16:08:08 GMT
• stocks making the biggest premarket moves: alibaba, dice therapeutics, avis and more MSN Fri, 17 May 2024 22:14:06 GMT
• lilly eyes targeted cancer therapies with $1.4 billion point biopharma deal Yahoo Canada Sports Fri, 17 May 2024 11:35:47 GMT
• we're not very worried about dice therapeutics' (nasdaq:dice) cash burn rate Yahoo Movies Canada Tue, 14 May 2024 16:25:55 GMT
• sands capital raises $555m fund amid upturn in biotech ‘crossover’ investing BioPharma Dive Tue, 14 May 2024 07:00:00 GMT
• arlington's sands capital raises hefty sum for third life sciences fund The Business Journals Tue, 14 May 2024 07:00:00 GMT
• dice therapeutics (dice) up 37% on buyout offer from eli lilly Yahoo Movies Canada Mon, 13 May 2024 14:25:57 GMT
• stocks making the biggest premarket moves: alibaba, dice therapeutics, avis and more MSN Thu, 09 May 2024 14:55:23 GMT
• dna-encoded library (del) technology market is booming across the globe by share, growth size, key segments... WhaTech Fri, 12 Apr 2024 07:00:00 GMT
• dice therapeutics (dice) up 37% on buyout offer from eli lilly Yahoo News Canada Mon, 01 Apr 2024 17:08:21 GMT
• wall street analysts think dice therapeutics, inc. (dice) could surge 93%: read this before placing a bet Yahoo Lifestyle UK Sat, 09 Mar 2024 05:23:27 GMT
• dice - lilly announces extension of tender offer to acquire dice br.ADVFN.com Thu, 07 Mar 2024 12:00:39 GMT
• changing faces: pharma and biotech hires from january 2024 Pharmaphorum Tue, 06 Feb 2024 08:00:00 GMT
• Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer Business Wire Wed, 03 Jan 2024 08:00:00 GMT
• spotlight on: key trends among 2023’s largest m&a deals FirstWord Pharma Fri, 22 Dec 2023 08:00:00 GMT
• fierce biotech m&a tracker 2023: bms, abbvie drop billions for neuropsychiatry biotechs Fierce Biotech Fri, 22 Dec 2023 08:00:00 GMT
• prism scores up to $660m from lilly in drug discovery deal BioWorld Online Tue, 05 Dec 2023 17:00:00 GMT
• el kremlin dice que los recortes de la opep+ tardarán en surtir efecto y confirma viaje de putin Yahoo Tue, 05 Dec 2023 10:10:00 GMT
• domine el dow y obtenga grandes dividendos con nuestros ... Investing.com México Tue, 05 Dec 2023 09:34:35 GMT
• esta startup acaba de recaudar 19 millones de dólares para llevar ... Forbes Perú Mon, 04 Dec 2023 17:54:30 GMT
• psoriasis pipeline assessment, 2023 updates: fda, ema, and pmda approvals, emerging drugs, clinical trials, and ... Digital Journal Mon, 04 Dec 2023 17:17:45 GMT
• inversores no pueden evitar la tentación de los fármacos contra la obesidad Bloomberg Línea English Mon, 04 Dec 2023 14:52:25 GMT
• prism scores up to $660m from lilly in drug discovery deal BioWorld Online Thu, 30 Nov 2023 21:53:32 GMT
• promise of new druggable targets drives lilly into $660m prism ... MM+M Online Thu, 30 Nov 2023 19:56:15 GMT
• as it happened: christopher luxon's first post-cabinet press ... The Spinoff Wed, 29 Nov 2023 02:48:12 GMT
• a fully automated deep-learning model for predicting the ... Cancer Discovery Tue, 21 Nov 2023 14:41:11 GMT
• eli lilly to expand injectable manufacturing capacity with new $2.5 ... PMLiVE Tue, 21 Nov 2023 08:00:00 GMT
• eisai and eli lilly triumph at the 19th annual scrip awards :: scrip Scrip Thu, 16 Nov 2023 23:01:34 GMT
• johnson analyzes combination immunotherapy in the first line in ... Targeted Oncology Wed, 15 Nov 2023 08:00:00 GMT
• cautious investor? 2 safe stocks you also can count on for growth The Motley Fool Sat, 11 Nov 2023 08:00:00 GMT
• forward therapeutics, the first biotech from curie.bio, raises $50m for oral small molecules in immunology Endpoints News Wed, 08 Nov 2023 08:00:00 GMT
• eli lilly slashed its earnings guidance and its stock went up 5 ... The Motley Fool Wed, 08 Nov 2023 08:00:00 GMT
• update: moonlake hopes another phase 2 win helps il-17 drug shine brighter in inflammatory race Fierce Biotech Mon, 06 Nov 2023 08:00:00 GMT
• moonlake shines brighter as il-17 drug scores latest phase 2 win FierceBiotech Mon, 06 Nov 2023 08:00:00 GMT
• 12 best small-cap biotech stocks with massive potential according ... Yahoo Finance Sat, 04 Nov 2023 07:00:00 GMT
• eli lilly and company (nyse:lly) q3 2023 earnings call transcript Yahoo Finance Sat, 04 Nov 2023 07:00:00 GMT
• lilly reports third-quarter 2023 financial results, highlights strong sales growth and business development activity Eli Lilly and Company Thu, 02 Nov 2023 07:00:00 GMT
• lilly's q3 sales jump 37% on mounjaro, verzenio sales FirstWord Pharma Thu, 02 Nov 2023 07:00:00 GMT
• glp-1 drugs carry lilly, novo; moderna tops revenue expectations Medical Marketing and Media Thu, 02 Nov 2023 07:00:00 GMT
• eli lilly stock rises despite slashing its outlook. weight-loss drugs are key. Barron's Thu, 02 Nov 2023 07:00:00 GMT
• tesla, nvidia, jpmorgan, citigroup, wells fargo, and more stock market movers Barron's Thu, 02 Nov 2023 07:00:00 GMT
• eli lilly enters crowded ulcerative colitis market with delayed fda approval for omvoh Fierce Pharma Fri, 27 Oct 2023 07:00:00 GMT
• delayed fda nod moves lilly to crowded ulcerative colitis market FiercePharma Fri, 27 Oct 2023 07:00:00 GMT
• q3 boasts solid biopharma mega-deals, more mergers, but 2023 ... BioWorld Online Tue, 24 Oct 2023 07:00:00 GMT
• biopharma won't stop betting big on m&a earnouts as payouts slow FierceBiotech Tue, 17 Oct 2023 07:00:00 GMT
• dna encoded library market set to reach $840 million in 2023 ... GlobeNewswire Tue, 17 Oct 2023 07:00:00 GMT
• bicara therapeutics appoints kate haviland and scott robertson to board citybiz Mon, 16 Oct 2023 07:00:00 GMT
• bicara therapeutics expands board of directors with appointments of kate haviland and scott robertson Business Wire Mon, 16 Oct 2023 07:00:00 GMT
• eli lilly’s mirikizumab hits key phase 3 goals in crohn’s disease Medical Marketing and Media Thu, 12 Oct 2023 07:00:00 GMT
• eli lilly's mirikizumab hits key phase 3 goals in crohn's disease MM+M Online Thu, 12 Oct 2023 07:00:00 GMT
• novartis cuts depression study, nearly erasing $210m cadent ... FierceBiotech Tue, 10 Oct 2023 07:00:00 GMT
• Eli Lilly acquires Point Biopharma for $1.4B: Employee rights Samfiru Tumarkin LLP Thu, 05 Oct 2023 07:00:00 GMT
• friday five (6 oct 2023) – deals aplenty, lilly moves and shakes, novartis spring cleans portfolio … and more FirstWord Thu, 05 Oct 2023 07:00:00 GMT
• eli lilly is on a buying spree. here's what it means for investors like us CNBC Thu, 05 Oct 2023 07:00:00 GMT
• lilly to enter radioligand therapy space with point biopharma buy FirstWord Pharma Tue, 03 Oct 2023 07:00:00 GMT
• lilly eyes targeted cancer therapies with $1.4 billion point biopharma deal Reuters Tue, 03 Oct 2023 07:00:00 GMT
• eli lilly to buy radiopharma company point biopharma for $1.4b as phiii readout looms Endpoints News Tue, 03 Oct 2023 07:00:00 GMT
• lilly shells out $1.4 billion for radioligand company The Pharma Letter Tue, 03 Oct 2023 07:00:00 GMT
• conscious re-coupling: m&a comes back surely, if slowly Genetic Engineering & Biotechnology News Thu, 21 Sep 2023 07:00:00 GMT
• researchers discover biomarker for tracking depression recovery National Institutes of Health (.gov) Wed, 20 Sep 2023 07:00:00 GMT
• lilly closes two $1b+ acquisitions in august as m&as pace similar to last year BioWorld Online Fri, 15 Sep 2023 07:00:00 GMT
• dice thinks it holds an ace with oral il-17 inhibitor in psoriasis Scrip Sun, 10 Sep 2023 18:44:47 GMT
• imbria pharmaceuticals completes enrollment in the phase 2 ... Diagnostic and Interventional Cardiology Fri, 08 Sep 2023 07:00:00 GMT
• pig kidney xenotransplantation performing optimally after 32 days ... NYU Langone Health Wed, 16 Aug 2023 07:00:00 GMT
• lilly completes spate of acquisitions Pharmaceutical Technology Magazine Tue, 15 Aug 2023 07:00:00 GMT
• lilly completes acquisition of dice therapeutics European Pharmaceutical Manufacturer Mon, 14 Aug 2023 07:00:00 GMT
• antitrust & competition life sciences quarterly update - q2 2023 JD Supra Mon, 14 Aug 2023 07:00:00 GMT
• lilly completes acquisition of dice therapeutics | eli lilly and company Investors | Eli Lilly and Company Wed, 09 Aug 2023 07:00:00 GMT
• eli lilly soars on blockbuster q2 earnings: etfs to tap Yahoo Finance Wed, 09 Aug 2023 07:00:00 GMT
• deal wrap: kohlberg to invest in engage peo; ta, warburg buy ... S&P Global Wed, 09 Aug 2023 07:00:00 GMT
• Lilly Completes Acquisition of DICE Therapeutics | Eli Lilly and Company Eli Lilly and Company Tue, 08 Aug 2023 07:00:00 GMT
• lilly reports second-quarter 2023 financial results, highlights accelerating revenue growth and key pipeline advancements | eli li... Eli Lilly and Company Tue, 08 Aug 2023 07:00:00 GMT
• lilly completes acquisition of dice therapeutics Investors | Eli Lilly and Company Tue, 08 Aug 2023 07:00:00 GMT
• top 5 health care stocks that may crash in q3 - biodesix (nasdaq:bdsx) Benzinga Mon, 07 Aug 2023 07:00:00 GMT
• dice therapeutics stock gains amid nasdaq delisting notice for eli lilly deal Seeking Alpha Wed, 02 Aug 2023 07:00:00 GMT
• flipping a switch and making cancers self-destruct The New York Times Mon, 31 Jul 2023 07:00:00 GMT
• eli lilly extends tender offer for $2.4bn dice acquisition Pharmaceutical Technology Wed, 26 Jul 2023 07:00:00 GMT
• lilly extends tender offer for $2.4bn dice acquisition Pharmaceutical Technology Wed, 26 Jul 2023 07:00:00 GMT
• Lilly Announces Extension of Tender Offer to Acquire DICE Eli Lilly and Company Tue, 25 Jul 2023 11:01:57 GMT
• psoriasis market to register immense growth by 2032, predicts delveinsight | key companies working in space ... GlobeNewswire Tue, 25 Jul 2023 07:00:00 GMT
• eli lilly extends tender offer to acquire dice (nyse:lly) Seeking Alpha Tue, 25 Jul 2023 07:00:00 GMT
• sanofi goes oral route in recludix deal to develop tailored i&i drugs MM+M Online Fri, 21 Jul 2023 07:00:00 GMT
• lly: should investors start watching eli lilly & co. (lly) this week? StockNews.com Tue, 18 Jul 2023 07:00:00 GMT
• Lilly bets up to $1.9B on Versanis' PhIIb weight loss drug alone and in combo with Novo Nordisk's Wegovy Endpoints News Fri, 14 Jul 2023 07:00:00 GMT
• exclusive: moonlake immunotherapeutics explores sale, sources say Reuters Fri, 14 Jul 2023 07:00:00 GMT
• hungry for more, lilly tops off weight loss pipeline with $1.9b deal to acquire versanis Fierce Biotech Fri, 14 Jul 2023 07:00:00 GMT
• lilly to buy versanis, adding to obesity drug pipeline BioPharma Dive Fri, 14 Jul 2023 07:00:00 GMT
DICE Therapeutics(NASDAQ:DICE) 
DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It designs and develops therapies in immunology for patients with chroni...
Share this website to your friends